万东医疗: 万东医疗董事会薪酬与考核委员会关于公司2025年股票期权激励计划预留授予激励对象名单（授予日）的核查意见

Core Viewpoint - The company has reviewed and approved the list of candidates for the 2025 stock option incentive plan, confirming compliance with relevant laws and regulations [1][2][3] Group 1: Incentive Plan Overview - The content of the incentive plan is consistent with what was approved at the 2024 annual shareholders' meeting [1] - The candidates for the incentive plan include current directors, senior management, core management, and key technical/business personnel, excluding independent directors, supervisors, and major shareholders [1][2] Group 2: Eligibility Criteria - All individuals included in the incentive plan meet the qualifications set forth by the Company Law, Securities Law, and the company's articles of association [2] - There are no disqualifying conditions as outlined in the management regulations, such as being deemed inappropriate by the stock exchange or the China Securities Regulatory Commission [2] Group 3: Granting Conditions - The conditions for granting the stock options have been met, and the designated grant date of August 22, 2025, is in accordance with the management regulations [3] - The board has approved the grant of 1.2 million stock options to 14 eligible candidates at an exercise price of 15.05 yuan per option [3]